{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:31:06Z","timestamp":1789428666807,"version":"build-2803163510"},"reference-count":36,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107499"],"award-info":[{"award-number":["107499"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["216444\/Z\/19\/Z"],"award-info":[{"award-number":["216444\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202800\/Z\/16\/Z"],"award-info":[{"award-number":["202800\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220266\/Z\/20\/Z"],"award-info":[{"award-number":["220266\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,5,11]]},"abstract":"\n Background:<\/jats:title>\n \n The long co-evolution of\n Homo sapiens<\/jats:italic>\n and\n Plasmodium falciparum<\/jats:italic>\n has resulted in the selection of numerous human genetic variants that confer an advantage against severe malaria and death. One such variant is the Dantu blood group antigen, which is associated with 74% protection against severe and complicated\n P. falciparum<\/jats:italic>\n malaria infections in homozygous individuals, similar to that provided by the sickle haemoglobin allele (HbS). Recent\n in vitro<\/jats:italic>\n studies suggest that Dantu exerts this protection by increasing the surface tension of red blood cells, thereby impeding the ability of\n P. falciparum<\/jats:italic>\n merozoites to invade them and reducing parasite multiplication. However, no studies have yet explored this hypothesis\n in vivo<\/jats:italic>\n .\n <\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n We investigated the effect of Dantu on early phase\n P. falciparum<\/jats:italic>\n (Pf) infections in a controlled human malaria infection (CHMI) study. 141 sickle-negative Kenyan adults were inoculated with 3.2 \u00d7 10\n 3<\/jats:sup>\n aseptic, purified, cryopreserved Pf sporozoites (PfSPZ Challenge) then monitored for blood-stage parasitaemia for 21 days by quantitative polymerase chain reaction (qPCR)analysis of the 18S ribosomal RNA\n P. falciparum<\/jats:italic>\n gene. The primary endpoint was blood-stage\n P. falciparum<\/jats:italic>\n parasitaemia of \u2265500\/\u03bcl while the secondary endpoint was the receipt of antimalarial treatment in the presence of parasitaemia of any density. On study completion, all participants were genotyped both for Dantu and for four other polymorphisms that are associated with protection against severe falciparum malaria: \u03b1\n +<\/jats:sup>\n -thalassaemia, blood group O, G6PD deficiency, and the rs4951074 allele in the red cell calcium transporter\n ATP2B4<\/jats:italic>\n .\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The primary endpoint was reached in 25\/111 (22.5%) non-Dantu subjects in comparison to 0\/27 (0%) Dantu heterozygotes and 0\/3 (0.0%) Dantu homozygotes (p=0.01). Similarly, 49\/111 (44.1%) non-Dantu subjects reached the secondary endpoint in comparison to only 7\/27 (25.9%) and 0\/3 (0.0%) Dantu heterozygotes and homozygotes, respectively (p=0.021). No significant impacts on either outcome were seen for any of the other genetic variants under study.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n \n This study reveals, for the first time, that the Dantu blood group is associated with high-level protection against early, non-clinical,\n P. falciparum<\/jats:italic>\n malaria infections\n in vivo<\/jats:italic>\n . Learning more about the mechanisms involved could potentially lead to new approaches to the prevention or treatment of the disease. Our study illustrates the power of CHMI with PfSPZ Challenge for directly testing the protective impact of genotypes previously identified using other methods.\n <\/jats:p>\n <\/jats:sec>\n \n Funding:<\/jats:title>\n The Kenya CHMI study was supported by an award from Wellcome (grant number 107499). SK was supported by a Training Fellowship (216444\/Z\/19\/Z), TNW by a Senior Research Fellowship (202800\/Z\/16\/Z), JCR by an Investigator Award (220266\/Z\/20\/Z), and core support to the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya (203077), all from Wellcome. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.<\/jats:p>\n <\/jats:sec>\n \n Clinical trial number:<\/jats:title>\n \n NCT02739763<\/jats:related-object>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.7554\/elife.83874","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T06:15:14Z","timestamp":1683872114000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.83874","source":"Crossref","is-referenced-by-count":17,"title":["The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study"],"prefix":"10.7554","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct02739763","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0801-5285","authenticated-orcid":true,"given":"Silvia N","family":"Kariuki","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04r1cxt79","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Research Programme","place":["Kilifi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W","family":"Macharia","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04r1cxt79","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Research Programme","place":["Kilifi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnstone","family":"Makale","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04r1cxt79","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Research Programme","place":["Kilifi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred","family":"Nyamu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04r1cxt79","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Research Programme","place":["Kilifi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Sanaria Incorporate","place":["Rockville, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C","family":"Kapulu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04r1cxt79","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Research Programme","place":["Kilifi, Kenya"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bejon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04r1cxt79","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Research Programme","place":["Kilifi, Kenya"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-1014","authenticated-orcid":true,"given":"Julian C","family":"Rayner","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/013meh722","id-type":"ROR","asserted-by":"publisher"}],"name":"Cambridge Institute for Medical Research, University of Cambridge","place":["Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-2382","authenticated-orcid":true,"given":"Thomas N","family":"Williams","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04r1cxt79","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Geographic Medicine Research (Coast), KEMRI-Wellcome Trust Research Programme","place":["Kilifi, Kenya"]},{"id":[{"id":"https:\/\/ror.org\/041kmwe10","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute for Global Health Innovation, Department of Surgery and Cancer, Imperial College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of for the CHMI-SIKA Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/bmj.1.4857.290","article-title":"Protection afforded by Sickle cell trait against Subtertian Malarial infection","volume":"1","author":"Allison","year":"1954","journal-title":"British Medical Journal"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature15390","article-title":"A novel locus of resistance to severe malaria in a region of ancient balancing selection","volume":"526","author":"Band","year":"2015","journal-title":"Nature"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-5-104","article-title":"Thick blood film examination for Plasmodium falciparum malaria has reduced sensitivity and Underestimates parasite density","volume":"5","author":"Bejon","year":"2006","journal-title":"Malaria Journal"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/513990","article-title":"Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge","volume":"175","author":"Church","year":"1997","journal-title":"The Journal of Infectious Diseases"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.15085","article-title":"Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe Malarial anaemia","volume":"6","author":"Clarke","year":"2017","journal-title":"eLife"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/hmg\/ddm331","article-title":"Common variation in the ABO Glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria","volume":"17","author":"Fry","year":"2008","journal-title":"Human Molecular Genetics"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00686","article-title":"Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using Sporozoites administered by Intramuscular injection","volume":"5","author":"Hodgson","year":"2014","journal-title":"Frontiers in Microbiology"},{"key":"bib8","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0541-6","article-title":"Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood Inoculum size in controlled human malaria infection studies","volume":"14","author":"Hodgson","year":"2015","journal-title":"Malaria Journal"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-288","article-title":"Measurement of Parasitological data by quantitative real-time PCR from controlled Human Malaria infection trials at the Walter Reed Army Institute of research","volume":"13","author":"Kamau","year":"2014","journal-title":"Malaria Journal"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14909.1","article-title":"Controlled Human Malaria Infection in semi-immune Kenyan adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity","volume":"3","author":"Kapulu","year":"2018","journal-title":"Wellcome Open Research"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146443","article-title":"Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection","volume":"6","author":"Kapulu","year":"2021","journal-title":"JCI Insight"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07044-8","article-title":"Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-Schizont antibody response","volume":"22","author":"Kapulu","year":"2022","journal-title":"BMC Infectious Diseases"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4049\/jimmunol.182.1.34","article-title":"Cutting edge: Autoimmune disease risk variant of Stat4 confers increased sensitivity to IFN-alpha in lupus patients in vivo","volume":"182","author":"Kariuki","year":"2009","journal-title":"Journal of Immunology"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-020-2726-6","article-title":"Red blood cell tension protects against severe malaria in the Dantu blood group","volume":"585","author":"Kariuki","year":"2020","journal-title":"Nature"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894770","article-title":"Breadth of antibodies to Plasmodium falciparum variant surface antigens is associated with immunity in a controlled human malaria infection study","volume":"13","author":"Kimingi","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037214","article-title":"\u03b1-Thalassemia impairs the Cytoadherence of Plasmodium falciparum-infected Erythrocytes","volume":"7","author":"Krause","year":"2012","journal-title":"PLOS ONE"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4269\/ajtmh.17-0343","article-title":"Impact of Sickle cell trait and naturally acquired immunity on uncomplicated malaria after controlled human malaria infection in adults in Gabon","volume":"98","author":"Lell","year":"2018","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ng.3107","article-title":"Reappraisal of known malaria resistance Loci in a large multicenter study","volume":"46","author":"Malaria Genomic Epidemiology Network","year":"2014","journal-title":"Nature Genetics"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0628-0","article-title":"Direct venous inoculation of Plasmodium falciparum Sporozoites for controlled human malaria infection: A dose-finding trial in two centres","volume":"14","author":"Mordm\u00fcller","year":"2015","journal-title":"Malaria Journal"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4269\/ajtmh.2012.10-0658","article-title":"Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials","volume":"86","author":"Murphy","year":"2012","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31640-6","article-title":"Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria","volume":"13","author":"Musasia","year":"2022","journal-title":"Nature Communications"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/S2352-3026(18)30107-8","article-title":"Human candidate Gene Polymorphisms and risk of severe malaria in children in Kilifi, Kenya: A case-control Association study","volume":"5","author":"Ndila","year":"2018","journal-title":"The Lancet. Haematology"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2014.10.006","article-title":"Mechanistic studies of the negative Epistatic malaria-protective interaction between Sickle cell trait and \u237a-thalassemia","volume":"1","author":"Opi","year":"2014","journal-title":"EBioMedicine"},{"key":"bib24","article-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2017","unstructured":"R Development Core Team. 2017. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. https:\/\/www.r-project.org."},{"key":"bib25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.2012.12-0613","article-title":"Controlled human malaria infections by intradermal injection of Cryopreserved Plasmodium falciparum Sporozoites","volume":"88","author":"Roestenberg","year":"2013","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"17471","DOI":"10.1073\/pnas.0705390104","article-title":"Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced Rosetting","volume":"104","author":"Rowe","year":"2007","journal-title":"PNAS"},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.984323","article-title":"Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth Dynamics","volume":"13","author":"Salkeld","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.4269\/ajtmh.19-0094","article-title":"Beyond blood Smears: qualification of Plasmodium 18S rRNA as a biomarker for controlled human malaria infections","volume":"100","author":"Seilie","year":"2019","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"Chad63-MVA-Vectored blood-stage malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"Sheehy","year":"2012","journal-title":"Molecular Therapy"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4269\/ajtmh.14-0119","article-title":"Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites","volume":"91","author":"Shekalaghe","year":"2014","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1473-3099(12)70055-5","article-title":"Haemoglobinopathies and the clinical epidemiology of malaria: A systematic review and meta-analysis","volume":"12","author":"Taylor","year":"2012","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030158","article-title":"The effect of \u237a+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya","volume":"3","author":"Wambua","year":"2006","journal-title":"PLOS Medicine"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1046\/j.1365-2141.2002.03610.x","article-title":"The membrane characteristics of Plasmodium falciparum-infected and -uninfected heterozygous \u237a\u2070thalassaemic erythrocytes","volume":"118","author":"Williams","year":"2002","journal-title":"British Journal of Haematology"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1182\/blood-2005-01-0313","article-title":"Both heterozygous and homozygous \u237a\u207athalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya","volume":"106","author":"Williams","year":"2005","journal-title":"Blood"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.hoc.2015.11.005","article-title":"Sickle cell disease in sub-Saharan Africa","volume":"30","author":"Williams","year":"2016","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"bib36","first-page":"465","volume-title":"Advances in Malaria Research","author":"Williams","year":"2017"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/83874\/elife-83874-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/83874\/elife-83874-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/83874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:11:29Z","timestamp":1697058689000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/83874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":36,"alternative-id":["10.7554\/eLife.83874"],"URL":"https:\/\/doi.org\/10.7554\/elife.83874","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.21.22280031","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.09.21.22280031","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.83874.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.83874.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.83874.sa0","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e83874"}}